Spinal Muscular Atrophy Gene Replacement Therapy

One in 11 thousand babies are born with spinal muscular atrophy, or SMA. It’s the number one genetic cause of death for infants. WVU Medicine Children’s Hospital neurologist Sara A. McGuire, MD, describes Zolgensma, a new gene replacement therapy treatment now  saving lives and improving outcomes.

About the Presenter

Sara A. McGuire, MD
Pediatric Neurology

Sign up for Clinical Advances e-news

and get regular updates emailed directly to your inbox such as:

    Latest procedures and services | New physicians and clinics | Clinical trials and innovations